Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ +1.56% inched 0.26% higher to $163.36 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +1.32% rising 2.07% to 4,686.75 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +1.37% rising 1.40% to 35,719.43. This was the stock's third consecutive day of gains. Johnson & Johnson closed $16.56 short of its 52-week high ($179.92), which the company achieved on August 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/composite RHHVF +1.95% fell 0.03% to $395.00, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK +1.77% fell 1.55% to $72.28, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE +2.25% rose 0.47% to $51.72. Trading volume (8.3 M) eclipsed its 50-day average volume of 7.3 M.